DOI:
10.1055/s-00034917
Kinder- und Jugendmedizin
LinksClose Window
References
Steinberg MH. et al
The risks and benefits of longterm use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up.
Am J Hematol 2010;
85 (06) 403-8.
Access:
We do not assume any responsibility for the contents of the web pages of other providers.